Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cutler

Showing results (531-540 of 543) with videos related to

Pageof 55
Sort By:
Blood|September 15, 2016
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factorsShernan G Holtan, Nandita Khera, John E Levine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Blood Advances|August 9, 2018
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802Shernan G Holtan, Todd E DeFor, Angela Panoskaltsis-Mortari, et al.
Blood Advances|May 10, 2018
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplantsAnita J Kumar, Soyoung Kim, Michael T Hemmer, et al.
Blood Advances|February 2, 2026
Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 DiseaseMarja Hakkarainen, Flore Sicre de Fontbrune, Ilse Kaaja, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remissionErica D Warlick, Kristjan Paulson, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
Bone Marrow Transplantation|December 13, 2016
GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomesY-B Chen, T Wang, M T Hemmer, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Pageof 55

Showing results (531-540 of 543) with videos related to

Sort By:
Pageof 55
Blood|September 15, 2016
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factorsShernan G Holtan, Nandita Khera, John E Levine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Blood Advances|August 9, 2018
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802Shernan G Holtan, Todd E DeFor, Angela Panoskaltsis-Mortari, et al.
Blood Advances|May 10, 2018
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplantsAnita J Kumar, Soyoung Kim, Michael T Hemmer, et al.
Blood Advances|February 2, 2026
Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 DiseaseMarja Hakkarainen, Flore Sicre de Fontbrune, Ilse Kaaja, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remissionErica D Warlick, Kristjan Paulson, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor LymphomaAlex F Herrera, Scott J Rodig, Joo Y Song, et al.
Bone Marrow Transplantation|December 13, 2016
GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomesY-B Chen, T Wang, M T Hemmer, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Pageof 55